Literature DB >> 20684966

Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody.

Yoshiyuki Ishii1, Keiko Tanaka, Kazunari Kondo, Takamasa Takeuchi, Seiichiro Mori, Tadahito Kanda.   

Abstract

Rabbit anti-HPV16 L2 serum (anti-P56/75) neutralizes multiple oncogenic human papillomaviruses (HPVs). We inoculated HeLa cells with HPV16 pseudovirus (16PV) and with anti-P56/75-bound 16PV (16PV-Ab). Both 16PV and 16PV-Ab attached equally well to the cell surface. However, the cell-attached L1 protein of 16PV became trypsin-resistant after incubation at 37°C, whereas approximately 20% of the cell-attached 16PV-Ab L1 remained trypsin-sensitive. Confocal microscopy of HeLa cells inoculated with 16PV revealed packaged DNA in the nucleus at 22h after inoculation; however, nuclear DNA was not detected in cells inoculated with 16PV-Ab. Electron microscopy of HeLa cells inoculated with 16PV showed particles located in multivesicular bodies, lamellar bodies, and the cytosol after 4h; no cytosolic particles were detected after inoculation with 16PV-Ab. These data suggest that anti-P56/75 inhibits HPV infection partly by blocking viral entry and primarily by blocking the transport of the viral genome to the nucleus.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20684966     DOI: 10.1016/j.virol.2010.07.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.

Authors:  Carla Cerqueira; Pilar Samperio Ventayol; Christian Vogeley; Mario Schelhaas
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

2.  Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis.

Authors:  Stephen DiGiuseppe; Wioleta Luszczek; Timothy R Keiffer; Malgorzata Bienkowska-Haba; Lucile G M Guion; Martin J Sapp
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

Review 3.  Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis.

Authors:  Xueli Li; Zhengyuan Gong; Linglin Zhang; Chen Zhao; Xianda Zhao; Xin Gu; Honglei Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.

Authors:  Malgorzata Bienkowska-Haba; Wioleta Luszczek; Timothy R Keiffer; Lucile G M Guion; Stephen DiGiuseppe; Rona S Scott; Martin Sapp
Journal:  Cell Microbiol       Date:  2017-01-23       Impact factor: 3.715

5.  A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection.

Authors:  Matthew P Bronnimann; Janice A Chapman; Chad K Park; Samuel K Campos
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

7.  Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection.

Authors:  Patricia M Day; Cynthia D Thompson; Rachel M Schowalter; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

Review 8.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

9.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15

Review 10.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.